Conflict of interest disclosures
Pedro Cahn has received grant support from ViiV and Receipt of honorariaor consultation fees: ViiV – Merck
Bonaventura Clotet is a scientific advisor to two spin-offs: Aelix Therapeutics SL and AlbaJuna Therapeutics SL.
Eugènia Negredo has received honoraria or consultation fees from Merck Sharp & Dohme Corp., ViiV Healthcare, and Janssen; and has participated in a sponsored speaker’s bureau by Merck Sharp & Dohme Corp., ViiV Healthcare, and Janssen.
Zulma Ortiz receipt of honoraria or consultation fees from Novartis, Sanofi and AMGEN.